SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 925.76 |
| Enterprise Value ($M) | 961.93 |
| Book Value ($M) | 5.89 |
| Book Value / Share | 0.09 |
| Price / Book | 157.17 |
| NCAV ($M) | -73.36 |
| NCAV / Share | -1.16 |
| Price / NCAV | -12.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.23 |
| Current Ratio | 2.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 150.36 |
| Assets | 229.61 |
| Liabilities | 223.72 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Medytox Inc. | |||
| 13G/A | BlackRock, Inc. | |||
| 13G/A | Tang Capital Management Llc | 7.70 | ||
| 13G/A | Perceptive Advisors Llc | 8.50 | 35.15 | |
| 13G/A | Nantahala Capital Management, LLC | |||
| 13G/A | Stonepine Capital Management, LLC | 2.20 | -74.31 | |
| 13G/A | Tang Capital Partners Lp | 5.40 | 1.93 | |
| 13G | Vanguard Group Inc | 5.15 | ||
| 13G/A | First Manhattan Co | 0.86 | -88.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,851 | 486,388 | 15.39 | |
| 75,767 | 369,079 | 20.53 | |
| 124,287 | 563,977 | 22.04 | |
| 88,775 | 401,991 | 22.08 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRVS – Corvus Pharmaceuticals, Inc. | CURR – CURRENC Group Inc. |
| CVAC – CureVac N.V. | ESPR – Esperion Therapeutics, Inc. |
| ETNB – 89bio, Inc. |
Financial data and stock pages provided by
Fintel.io